Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Receivables (2018 - 2025)

Historic Receivables for Zai Lab (ZLAB) over the last 8 years, with Q3 2025 value amounting to $85.4 million.

  • Zai Lab's Receivables rose 7085.65% to $85.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.4 million, marking a year-over-year increase of 7085.65%. This contributed to the annual value of $85.2 million for FY2024, which is 4388.42% up from last year.
  • As of Q3 2025, Zai Lab's Receivables stood at $85.4 million, which was up 7085.65% from $88.5 million recorded in Q2 2025.
  • In the past 5 years, Zai Lab's Receivables registered a high of $88.5 million during Q2 2025, and its lowest value of $8.8 million during Q1 2021.
  • Moreover, its 5-year median value for Receivables was $47.3 million (2023), whereas its average is $49.0 million.
  • In the last 5 years, Zai Lab's Receivables skyrocketed by 81914.81% in 2021 and then tumbled by 1582.13% in 2022.
  • Quarter analysis of 5 years shows Zai Lab's Receivables stood at $47.5 million in 2021, then dropped by 15.82% to $40.0 million in 2022, then soared by 48.13% to $59.2 million in 2023, then skyrocketed by 43.88% to $85.2 million in 2024, then grew by 0.23% to $85.4 million in 2025.
  • Its Receivables stands at $85.4 million for Q3 2025, versus $88.5 million for Q2 2025 and $76.6 million for Q1 2025.